Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02781051 · ClinicalTrials.gov registry record · NA

Increasing Physical Activity Among Breast Cancer Survivors With Depression

A NA study of Breast Cancer and Depression, sponsored by University of Texas Southwestern Medical Center.

Completed
Registry status
NA
Development phase
16
Enrollment target
1
Study location

NCT02781051: Completed NA study of Breast Cancer and Depression, sponsored by University of Texas Southwestern Medical Center.

NCT02781051 is a NA study of Breast Cancer and Depression that has completed, run by University of Texas Southwestern Medical Center. The registered enrollment target is 16 participants, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02781051, a NA study of Breast Cancer and Depression, has completed, sponsored by University of Texas Southwestern Medical Center.

COMPLETED
Registry status
NA
Development phase
16 participants
Enrollment target
1
Study location

Study Summary

Pilot study to assess a multi-component intervention to increase physical activity among breast cancer survivors with depression.

Primary Outcome

Assess changes in physical activity at 6 months following physical activity intervention.

Interventions

  • DEVICE Fitbit
  • BEHAVIORAL Print-based education
  • BEHAVIORAL Active Living counseling
  • OTHER Facility Access

Study Locations (1)

Texas

  • UT Southwestern Medical Center - Dallas

Trial Details

FieldValue
Enrollment Target 16 participants
Start Date 2016-05
Est. Completion 2017-09
Phase NA

What the finished NCT02781051 record still lists

NCT02781051 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 16 participants, a relatively small participant target, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (99% lower).

The record links to 3 conditions, with Breast Cancer appearing as the primary indexed condition, and to 4 interventions - of which Fitbit is the first listed.

NCT02781051 reports a single indexed study location in Texas.

Frequently Asked Questions

What is clinical trial NCT02781051 about?

NCT02781051 is a clinical study titled "Increasing Physical Activity Among Breast Cancer Survivors With Depression". Pilot study to assess a multi-component intervention to increase physical activity among breast cancer survivors with depression.

What is the current status of trial NCT02781051?

This trial is currently completed. It is a NA study. The enrollment target is 16 participants. The study started on 2016-05. Estimated completion is 2017-09.

What conditions does trial NCT02781051 study?

This clinical trial studies the following conditions: Breast Cancer, Depression, Physical Activity.

What interventions are being tested in trial NCT02781051?

The interventions under investigation include: Fitbit (DEVICE), Print-based education (BEHAVIORAL), Active Living counseling (BEHAVIORAL), Facility Access (OTHER).

Who is sponsoring clinical trial NCT02781051?

This trial is sponsored by University of Texas Southwestern Medical Center, which has 837 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02781051 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Breast Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT02781051's enrollment target sits among peer trials

16 1135th of 1224 higher than 82 of 1,224 other Breast Cancer trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Breast Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02422641 · 16 participants · Phase 2

    Prospective Evaluation Of High-Dose Systemic Methotrexate In Patients With Breast Cancer And Leptomeningeal Metastasis

  • NCT02851758 · 16 participants · NA

    Transplantation of Autologously Derived Mitochondria Following Ischemia

  • NCT03291028 · 16 participants

    Analysis of Primary and Metastatic Tumors in Patients With Renal Cell Carcinoma and Urothelial Carcinoma

  • NCT03425526 · 16 participants · Phase 1

    Donor T Cell Therapy in Treating Immunocompromised Patients With Adenovirus-Related Disease

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02781051, the US trial registry maintained by the National Library of Medicine. NCT02781051 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.